Please assess the completion status of the following clinical trial:

Trial Title: Magnesium Sulfate Improves Postoperative Analgesia in Laparoscopic Gynecologic Surgeries

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* ASA I-II female patients undergoing laparoscopic gynecologic oncology surgeries, for treatment of cancer~Exclusion Criteria:~* chronic pain, cardiovascular, hepatic or renal disease, neuromuscular disease, diabetes, drugs or alcohol abuse, obesity, patients treated with calcium channel blockers or magnesium, allergy or contraindication to any of the drugs studied.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- ketorolac (Type: ACTIVE_COMPARATOR): intravenous ketorolac (30 mg) is injected in bolus, followed by continuous infusion of saline solution (Group K) during the surgical procedure
- magnesium (Type: EXPERIMENTAL): intravenous magnesium sulfate (20 mg/kg) is injected in bolus, followed by continuous infusion of magnesium sulfate (2 mg/kg/h) (Group M) during the surgical procedure
- saline (Type: PLACEBO_COMPARATOR): intravenous saline solution (20 ml) is injected in bolus, followed by continuous infusion of saline infusion during the entire procedure (Group S).

Based on this trial design, predict the completion outcome and termination type (if applicable).